One of the biggest concerns in the administration of hazardous drugs is the risk to those who come into contact with these drugs: patients, nurses and other health care professionals who administer the drug. Read this month’s editorial to explore ways of reducing these risks
The use of hazardous drugs (HD) for example cytotoxic drugs to treat cancer, has increased exponentially over the last 40 years. Sadly, however the awareness of the risks in administering HD has not increased at the same rate. Hear what two nurses have to say about the role of nurses in the handling of these drugs and what controls can be put in place to help mitigate the risks.
This one-pager summarises key information from three important documents for engineering controls: a joint position statement from the Oncology Nursing Society and the Hematology/Oncology Pharmacy Assocation, the USP <800>, and the NIOSH Hierarchy of Controls
All healthcare professionals, and especially hospital pharmacists, need to concern themselves with ensuring the quality of injectable medications. This module explores the technologies used to maintain product integrity from preparation to administration. Watch Johan Vandenbrouke briefly introduce his updated module.